• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Efficacy of clinical follow-up of patients with tuberculosis of the respiratory organs in terms of their cure under present-day epidemiological conditions].

作者信息

Kovaleva S I, Voloshina E P, Shmakova K N

机构信息

Central NII of Tuberculosis, Moscow.

出版信息

Probl Tuberk. 1996(6):25-7.

PMID:9019761
Abstract

A total of 884 newly detected patients with tuberculosis of the respiratory organs with degradation were followed up for 9 years (1987-1995). Control group consisted of 1419 patients with respiratory tuberculosis without degradation. As a result of treatment, the destruction focus was healed in 3 years in 73.4% patients and bacteria no longer released in 77.4%. Remote results (after 3, 6, and 9 years) indicate that adequate treatment helps attain cure during the second and third year of the follow-up. Untimely transfer of the patients into inactive groups (40.4% after 3 years) leads to early relapses of tuberculosis, and thus groups of chronic patients are formed both among tuberculosis patients with initially detected destruction and without it (4.5 and 2.2%, respectively). The number of clinically cured patients by the end of the ninth year was 56.6 and 77%, respectively; 7.4 and 4.7% patients were still registered in the active groups.

摘要

相似文献

1
[Efficacy of clinical follow-up of patients with tuberculosis of the respiratory organs in terms of their cure under present-day epidemiological conditions].
Probl Tuberk. 1996(6):25-7.
2
Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.复治和违约肺结核患者的治疗结果
Int J Tuberc Lung Dis. 2002 Apr;6(4):320-5.
3
[Mycobacterium tuberculosis resistance in newly diagnosed patients and in patients with disease relapse].新诊断患者及疾病复发患者中的结核分枝杆菌耐药性
Probl Tuberk Bolezn Legk. 2003(5):19-21.
4
[Late results of strictly supervised treatment of patients with newly detected pulmonary tuberculosis].[新发现肺结核患者严格监督治疗的远期结果]
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1980 Jul-Sep;29(3):143-8.
5
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].[耐异烟肼或耐利福平结核病的特征及治疗结果]
Kekkaku. 2003 Oct;78(10):611-7.
6
[Dynamics of isolation of mycobacterium tuberculosis during 2-stage standard chemotherapy].
Probl Tuberk. 1996(6):52-4.
7
[The current aspects of the recurrence of tuberculosis of the respiratory organs in adults].[成人呼吸器官结核病复发的当前情况]
Probl Tuberk. 1996(4):2-4.
8
[Genetic marking of polyresistant mycobacterium tuberculosis strains isolated in the north-west of Russia].[俄罗斯西北部分离出的多重耐药结核分枝杆菌菌株的基因标记]
Probl Tuberk. 1999(3):39-41.
9
[Sociomedical aspects of detection and treatment of patients with tuberculosis under present conditions].[当前条件下结核病患者检测与治疗的社会医学方面]
Probl Tuberk. 1997(6):15-7.
10
[Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains].[伴有单纯耐药或敏感菌株的肺结核患者30年随访结果]
Probl Tuberk. 1997(5):12-5.